Suthiram J, Pieters A, Mohamed Moosa Z, Zeevaart J, Sathekge M, Ebenhan T
Int J Mol Sci. 2023; 24(3).
PMID: 36768456
PMC: 9916806.
DOI: 10.3390/ijms24032134.
Veldkamp M, Geuzebroek G, Baartscheer A, Verkerk A, Schumacher C, Suarez G
Nat Commun. 2018; 9(1):4357.
PMID: 30341287
PMC: 6195571.
DOI: 10.1038/s41467-018-06530-5.
Wang T, Chen S, Wang S, Shi L, Wang C, Zhang J
Oncotarget. 2017; 8(25):40713-40723.
PMID: 28489574
PMC: 5522309.
DOI: 10.18632/oncotarget.17250.
Jensen D, Halls M, Murphy J, Canals M, Cattaruzza F, Poole D
J Biol Chem. 2014; 289(29):20283-94.
PMID: 24898255
PMC: 4106342.
DOI: 10.1074/jbc.M114.578179.
Jayasena C, Comninos A, de Silva A, Abbara A, Veldhuis J, Nijher G
J Clin Endocrinol Metab. 2013; 99(1):E19-27.
PMID: 24170109
PMC: 3952021.
DOI: 10.1210/jc.2012-2880.
Current and future applications of GnRH, kisspeptin and neurokinin B analogues.
Millar R, Newton C
Nat Rev Endocrinol. 2013; 9(8):451-66.
PMID: 23817290
DOI: 10.1038/nrendo.2013.120.
Endosomal endothelin-converting enzyme-1: a regulator of beta-arrestin-dependent ERK signaling.
Cottrell G, Padilla B, Amadesi S, Poole D, Murphy J, Hardt M
J Biol Chem. 2009; 284(33):22411-22425.
PMID: 19531493
PMC: 2755963.
DOI: 10.1074/jbc.M109.026674.
Endothelin-converting enzyme 1 promotes re-sensitization of neurokinin 1 receptor-dependent neurogenic inflammation.
Cattaruzza F, Cottrell G, Vaksman N, Bunnett N
Br J Pharmacol. 2009; 156(5):730-9.
PMID: 19222484
PMC: 2697762.
DOI: 10.1111/j.1476-5381.2008.00039.x.
Chronic inflammation alters the contribution of neurokinin receptor subtypes to epithelial function in rat colon.
Appleyard C, Morales M, Santiago C
Dig Dis Sci. 2007; 53(1):220-8.
PMID: 17510797
DOI: 10.1007/s10620-007-9847-8.
Regional variations in neurokinin receptor subtype contributions to muscularis mucosae and epithelial function in rat colon.
Appleyard C, Morales M, Percy W
Dig Dis Sci. 2006; 51(3):506-16.
PMID: 16614960
DOI: 10.1007/s10620-006-3163-6.
Functional characterization of tachykinin NK1 receptors in the mouse uterus.
Patak E, Pennefather J, Fleming A, Story M
Br J Pharmacol. 2002; 137(8):1247-54.
PMID: 12466234
PMC: 1573619.
DOI: 10.1038/sj.bjp.0704996.
Evidence for a GABA(B) receptor component in the spinal action of Substance P (SP) on arterial blood pressure in the awake rat.
Brouillette J, Couture R
Br J Pharmacol. 2002; 136(8):1169-77.
PMID: 12163350
PMC: 1573441.
DOI: 10.1038/sj.bjp.0704813.
Human colonic anti-secretory activity of the potent NK(1) antagonist, SR140333: assessment of potential anti-diarrhoeal activity in food allergy and inflammatory bowel disease.
Moriarty D, Goldhill J, Selve N, ODonoghue D, Baird A
Br J Pharmacol. 2001; 133(8):1346-54.
PMID: 11498521
PMC: 1621146.
DOI: 10.1038/sj.bjp.0704194.
Tachykinin-induced contraction of the guinea-pig isolated oesophageal mucosa is mediated by NK(2) receptors.
Kerr K, Thai B, Coupar I
Br J Pharmacol. 2000; 131(7):1461-7.
PMID: 11090121
PMC: 1572466.
DOI: 10.1038/sj.bjp.0703708.
Desensitization of the neurokinin-1 receptor (NK1-R) in neurons: effects of substance P on the distribution of NK1-R, Galphaq/11, G-protein receptor kinase-2/3, and beta-arrestin-1/2.
McConalogue K, Corvera C, Gamp P, Grady E, Bunnett N
Mol Biol Cell. 1998; 9(8):2305-24.
PMID: 9693383
PMC: 25486.
DOI: 10.1091/mbc.9.8.2305.
Functional expression of a novel human neurokinin-3 receptor homolog that binds [3H]senktide and [125I-MePhe7]neurokinin B, and is responsive to tachykinin peptide agonists.
Krause J, Staveteig P, Mentzer J, Schmidt S, Tucker J, Brodbeck R
Proc Natl Acad Sci U S A. 1997; 94(1):310-5.
PMID: 8990205
PMC: 19326.
DOI: 10.1073/pnas.94.1.310.
Modulation of cortical acetylcholine release by serotonin: the role of substance P interneurons.
Feuerstein T, Gleichauf O, Landwehrmeyer G
Naunyn Schmiedebergs Arch Pharmacol. 1996; 354(5):618-26.
PMID: 8938661
DOI: 10.1007/BF00170837.
Study of SR 142801, a new potent non-peptide NK3 receptor antagonist on cardiovascular responses in conscious guinea-pig.
Roccon A, Marchionni D, Nisato D
Br J Pharmacol. 1996; 118(5):1095-102.
PMID: 8818331
PMC: 1909579.
DOI: 10.1111/j.1476-5381.1996.tb15511.x.
Effect of SR 142801 on nitric oxide-dependent and independent responses to tachykinin NK3 receptor agonists in isolated guinea-pig colon.
Giuliani S, Maggi C
Naunyn Schmiedebergs Arch Pharmacol. 1995; 352(5):512-9.
PMID: 8751080
DOI: 10.1007/BF00169385.
Comparative behavioural profile of centrally administered tachykinin NK1, NK2 and NK3 receptor agonists in the guinea-pig.
Piot O, Betschart J, Grall I, Ravard S, Garret C, Blanchard J
Br J Pharmacol. 1995; 116(5):2496-502.
PMID: 8581290
PMC: 1909059.
DOI: 10.1111/j.1476-5381.1995.tb15101.x.